CI
ACAD icon

Cowen Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

Cowen Inc’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-7,500
Closed -$115 – 503
2018
Q2 		$115 Buy
+7,500
New +$134K 0.01% 356
2016
Q3 		– Sell
-17,500
Closed -$568K – 231
2016
Q2 		$568K Buy
+17,500
New +$586K 0.05% 155
2016
Q1 		– Sell
-9,480
Closed -$338K – 253
2015
Q4 		$338K Buy
+9,480
New +$334K 0.04% 224
2015
Q3 		– Sell
-5,000
Closed -$209K – 250
2015
Q2 		$209K Sell
5,000
-36,300
-88% -$1.4M 0.02% 360
2015
Q1 		$1.35M Buy
+41,300
New +$1.42M 0.12% 111

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return